Literature DB >> 2938855

Late-onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function.

H Verder, E Dickmeiss, S Haahr, E Kappelgaard, J Leerbøy, A Møller-Larsen, H Nielsen, P Platz, C Koch.   

Abstract

We studied a classical case of late-onset rubella syndrome characterized by multi-organ disease and persistence of live rubella virus in spite of high titres of specific antirubella antibodies and presence of large amounts of circulating immune complexes. When first studied at the age of 5 months there was a low proportion of T8+ lymphocytes. Functional studies revealed decreased activity of K and NK cells as well as alloreactive direct cytotoxic cells (CTL). Removal of cell-bound immunoglobulin and immune complexes tended to improve K and NK cell function in vitro. Plasma exchange transfusions carried out at 9 months of age resulted in clinical improvement. Normalization of cytotoxic effector cell functions and cessation of viremia accompanied recovery from active disease. The results indicate that defective cytotoxic effector cell function is the primary cause for the defective virus elimination in this syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938855      PMCID: PMC1577388     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  CYTOPATHIC EFFECT OF RUBELLA VIRUS IN A RABBIT-CORNEA CELL LINE.

Authors:  J LEERHOY
Journal:  Science       Date:  1965-08-06       Impact factor: 47.728

2.  Administration of interferon to an infant with congenital rubella syndrome involving persistent viremia and cutaneous vasculitis.

Authors:  A Larsson; M Forsgren; S Hård af Segerstad; H Strander; K Cantell
Journal:  Acta Paediatr Scand       Date:  1976-01

3.  No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.

Authors:  K E Mogensen; L Pyhälä; E Törmä; K Cantell
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

4.  Immunological in vitro parameters in patients with multiple sclerosis and in normal individuals.

Authors:  P Platz; T Fog; N Morling; A Svejgaard; G Sonderstrup; L P Ryder; M Thomsen; C Jersild
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-12

5.  MLC and CML studies in the family of a pair of HLA haploidentical chimeric twins.

Authors:  M Thomsen; H E Hansen; E Dickmeiss
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

6.  A differential effect of IgM and IgG antibodies on the blastogenic response of lymphocytes to rubella virus.

Authors:  J C Lee; M M Sigel
Journal:  Cell Immunol       Date:  1974-07       Impact factor: 4.868

7.  Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection.

Authors:  S B Greenberg; B S Criswell; H R Six; R B Couch
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

8.  Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis.

Authors:  M L Weil; H Itabashi; N E Cremer; L Oshiro; E H Lennette; L Carnay
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

9.  Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.

Authors:  S Haahr; L Rasmussen; T C Merigan
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  Circulating immune complexes containing rubella antigens in late-onset rubella syndrome.

Authors:  M Tardieu; B Grospierre; A Durandy; C GAriscelli
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

View more
  3 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages.

Authors:  M L Linn; L Mateo; J Gardner; A Suhrbier
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 3.  Interactions of viruses with the immune system.

Authors:  C A Mims
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.